Inari Medical Inc Surges Past Analyst Target Price

Inari Medical Inc (NARI) sees shares exceed $65.38 target, now trading at $79.45. Investors must assess future performance against this benchmark amidst varying analyst opinions.

Date: 08-01-2025

AI Rating: 7

Stock Performance and Analyst Ratings
Inari Medical Inc (NARI) shares have recently surpassed the average analyst target price of $65.38, currently trading at $79.45. This breach signals potential for future growth but may also prompt analysts to reevaluate their target pricing. Many analysts are contributing to the target estimates, with one analyst suggesting a low target of $50.00 and another positing a higher target of $86.00. The significant standard deviation of $10.243 indicates diverse expectations among analysts.

Current Analyst Ratings
The current analyst ratings show a positive sentiment towards NARI, with 10 strong buy ratings and 5 hold ratings, while no sell or strong sell ratings are present. The average rating standing at 1.67, where a lower number denotes a more favorable view, reflects a strong buy consensus among the analysts. This favorable positioning adds to the bullish outlook for Inari Medical Inc.

Stocks: NARI